AbbVie (ABBV) Change in Inventory (2012 - 2026)

AbbVie has disclosed Change in Inventory across 15 years of filings, most recently posting $184.0 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 18.71% year-over-year to $184.0 million; the TTM figure through Mar 2026 stood at $263.0 million (down 34.09% YoY), while the FY2025 annual figure was $234.0 million, down 26.65% from the prior year.
• Change in Inventory improved to $184.0 million in Q1 2026, from $25.0 million in the prior quarter.
• Over the last five years, Change in Inventory for ABBV reached as high as $385.0 million in Q1 2022 and fell as low as -$96.0 million in Q4 2023.
• The 5-year median for Change in Inventory is $75.0 million (2024), against an average of $108.2 million.
• Annual changes were most pronounced in 2023 — Change in Inventory plunged 156.47% — and 2024, when it surged 233.33%.
• A 5-year view of Change in Inventory shows it stood at $170.0 million in 2022, then tumbled by 156.47% to -$96.0 million in 2023, then surged by 233.33% to $128.0 million in 2024, then slumped by 80.47% to $25.0 million in 2025, then surged by 636.0% to $184.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $184.0 million, $25.0 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.